of Toxiocology and Environmental Health (JTEH)
Residential Radon and Lung Cancer:
End of the Story?
A large study of the risks of radon shows that it can cause cancer at levels
even below those previously recommended, according to research published
in a special issue of the Journal of Toxicology and Environmental
Health, Part A (Volume 69, Numbers 7-8) in 2006 with Guest
Editors Jan M. Zielinski and R. William Field.
The study, which pooled data from seven North American residential radon
studies, showed that exposure to radon concentrations of 3.0 picocuries
per liter (pCi/L) of air increased the risk of lung cancer 11 to 21 percent
during an exposure period of five to 30 years. The U.S. Environmental Protection
Agency's currently recommends reducing radon levels if they exceed 4.0
“Findings from this large-scale epidemiologic study provide direct
evidence that residential radon exposure is a major public health concern,” says
William Field, one of the co-editors of the special issue and associate professor
of occupational and environmental health and epidemiology at the University
of Iowa. “The findings of the study indicate that prolonged
residential radon exposure even under the U.S. Environmental Protection Agency's
action level of 4 pCi/L significantly increases lung cancer risk.”
Radon is a naturally occurring, odourless, radioactive gas that is generated
by the decay of uranium in the soil and accumulates in enclosed areas such
as basements. It is the leading cause of lung cancer among nonsmokers,
causing 21,000 deaths in the U.S. each year, according to the EPA.
It has been known since the 1970s from studies of miners and animals that
high concentrations of radon are associated with lung cancer. However,
prior case-control studies of residential radon exposure have had conflicting
results. Some indicate a weak association between radon levels and
lung cancer while others show no association.
The current study pooled data from seven studies conducted in Connecticut,
Iowa, New Jersey, Missouri, and Utah, South Idaho, and Winnipeg, Canada. A
total of 3,662 cases and 4,966 controls represents the largest epidemiologic
study of radon ever performed in North America. Its results agree
with a similar pooled study of data from 13 European studies involving
7,148 cases and 14,208 controls.
“The North American and European pooling provides unambiguous and direct
evidence of an increased lung cancer risk even at residential radon exposure
levels below the U.S. EPA's action level," says Dr. Field.
In addition to the combined analysis of the seven studies, the special
issue of the Journal of Toxicology and Environmental Health,
Part A includes papers on exposure measurement, radon dosimetry,
and epidemiologic methods, as well as a section on radon risk management
that includes reports on two recent workshops sponsored by Health Canada
and the World Health Organization on the subject.
“Policies for testing and control can now be based with confidence in
the assumption that risk increases with concentration and that a ‘safe’ concentration
cannot be specified,” says Dr. Jonathan Samet of the Johns Hopkins University
School of Public Health in his preface to the special issue. Samet, who
served as chair of the U.S. National Research Council Committee on the Biological
Effects of Ionizing Radiation (BEIR VI), says that the studies suggest a linear,
dose-response, non-threshhold relationship between exposure to radon and lung
Published twenty-four times per year, the Journal of Toxicology
and Environmental Health, Part A features strictly refereed
original research in the field of environmental toxicology in general as
well as in special interest fields such as target organ toxicities, immunotoxicology,
risk assessment, carcinogenesis, mutagenesis, ecotoxicology, environmental
factors affecting health, and aquatic toxicology.
Subscription information for the Journal of Toxicology
and Environmental Health, Part A or a sample copy can be
obtained from the address below. To view the special issue (Vol.
69, Numbers 7-8), go to www.tandf.co.uk/journals/titles/15287394.asp.
|For subscription information, or to order
a sample copy, contact:
Taylor & Francis
Customer Service Department
325 Chestnut St., Ste 800
Philadelphia, PA 19106
or Phone: 1-800-354-1420 Ext. 216
or Email: email@example.com
|To submit an article, contact:
Dr. Sam Kacew
McLaughlin Centre for Population Health Risk Assessment
Institute of Population Health, Room 310
University of Ottawa